Phytomenadione (Konakion MM) Inj 2 mg per 0.2 ml: Supply issue
There has been a supply issue affecting Konakion MM (Inj 2 mg per 0.2 ml) Pharmacode 911828.
15 April 2025 Update
Stock is available. Pharmac has listed another alternative to ensure continuity of supply over the coming months. The alternative can be used as an approved medicine, Medsafe has granted a labelling exemption.
Affected product
This product is mostly used in hospitals, however some stock is used in the community.
- Chemical: Phytomenadione
- Presentation: Inj 2 mg per 0.2 ml - Up to 5 inj
- Brand: Konakion MM
- Pharmacode: 911828
- Subsidy: $8.00
- Measure / Qty: per 5
The Inj 10 mg per ml, 1 ml presentation (Pharmacode 298204) is unaffected by this issue.
Schedule listing for phytomenadione(external link)
HML listing for phytomenadione(external link)
Alternative product listed 1 May 2025
We have listed an alternative from 1 May 2025. This product is made by the same manufacturer, however it is labelled for a different country. The strength and dosage remains the same. There is an insert included in the box, please disregard the information on dosage included in the box and refer to the Medsafe Datasheet for Konakion [PDF](external link)
- Chemical: Phytomenadione
- Presentation: Inj 2 mg per 0.2 ml
- Brand: Konakion MM
- Pharmacode: 2703572
This product has a labelling exemption from Medsafe. It can be prescribed, dispensed and given as a registered NZ medicine. The supplier is including a letter outlining the differences in packaging with every pack of the alternative Konakion to health care professionals.


Limited supply expected May/June 2025
We have listed an alternative in expectation of tight supply to begin in May and June 2025 and last until late 2025. Following that, the supplier expects supply to return to normal.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)